1 / 33

Skin Cancer

Skin Cancer . Amy Stinson ENT Resident Affinity Medical Center. Skin Cancer. Most common human malignancy US: >1,300,000 cases annually 2,000 deaths annually (non-melanoma) Most common location – sun exposed areas of head and neck Basal Cell accounts for 90% (baileys)

brittany-graves
Télécharger la présentation

Skin Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Skin Cancer Amy Stinson ENT Resident Affinity Medical Center

  2. Skin Cancer • Most common human malignancy • US: >1,300,000 cases annually • 2,000 deaths annually (non-melanoma) • Most common location – sun exposed areas of head and neck • Basal Cell accounts for 90% (baileys) • Squamous cell next most common, then melanoma • Pearls: What is the reported ratio of BCC to SCC in the US? • 4:1

  3. Skin Cancer Risk Factors • Age > 60 • UV light exposure • Pearls: specifically UV B (280-320nm) • Specific Traits: fair complexion, blue/green eyes, light hair, inability to tan, celctic ancestry • Hx of multiple or severe sunburns • Tanning bed use • Mainly UV A – UV A synergistically augments UV B response • Arsenic exposure • Chronic radiodermatits (pearls) • Immunosuppression (pearls) • Trauma: burns, ulcers or scars • Pearls: Marjolin Ulcer

  4. Risk Factors

  5. Risk Factors • Genetic disorders (Pearls) • Basal Cell-Nevoid Syndrome (Grolin’s) • Aut Dom, multiple BCC, odontogenic keratocysts, rib abnormailties, palmar/plantar pits, calcification of falx cerebri • Xeroderma pigmentosa • Albinism • Epidermisdysplastic verruciformis • Epidermolysis bullosa dystrophica • Dyskeratosis congenital

  6. Normal Skin

  7. Normal Skin • 5 layers of epidermis from superficial to deep (Pearls) • Stratum Corneum • Stratum Lucidum • Stratum Granulosum • Stratum Spinosum • Stratum Basale • Pneumonic: • Come, Let’s Get Sun Burned

  8. Basal Cell • Slowly growing malignancy of the epidermis • Extends peripherally without vertical invasion • Rarely metastasizes • Cells appear histologically similar to basal cells of epidermis (small dark blue cells with little cytoplasm) • BCC – clefting, lack of intracellular bridges, nuclear pallisading, peritumoral lucunae

  9. Basal Cell Growth pattern (pearls) Follows the path of least resistance Typically along embryonic fusion planes Susceptible areas: Inner canthus Philtrum Mid - Lower chin Nasolabial groove Periauricular area Retroauricular sulcus

  10. Basal Cell • Clinical subtypes (pearls) • Nodular – Most Common • Pearly, telangiectatic papule, central ulceration, rolled border • Superficial • Rare in H & N, scaly, waxy, indurated, irregular • More common on extremeties and trunk • Pigmented/Cystic • Similar to nodular type, more pigmented resembling melanoma or benign nevus • Morpheaform • Common on face, flat or depressed, indurated, aggressive with high rate of recurrence, worst prognosis, can resemble scar • Keratotic • aggressive

  11. Basal Cell Superficial Nodular Pigmented

  12. Basal Cell Morpheaform Post - excision

  13. Basal Cell • Management • Avoid excess sun – sunblock • Careful follow-up for recurrence • Pearls: After having one (BCC or SCC) what are the chances of developing another within 5 yrs? • 50% • Curettage with Electrodisiccation • Cryosurgery • Scalpel excision – need 5 mm margins • Radiation therapy – poor operative candidates • Mohs – for high risk areas, morpheaform • 1/3 of incompletely excised BCC will recur

  14. Squamous Cell • More aggressive • Higher recurrence rates • Vertical extension • 1-4% metastatic potential • Scar/chronic inflam > de novo > from AK • Signs: • Erythematous, hyperkeratotic, opaque nodule, ulcerative, granular base, bleeds easily • SCC that arise in sun exposed areas have better prognosis than those arising de novo

  15. Squamous Cell • Histopath • Keratin pearls • Broder Classification • 1 – well differentiated • 4 – poorly differentiated • Types: • Adenoid • Bowenoid • Verrucus – mc in oral mucosa • Spindle-pleomorphic – least common • Generic – from actinic change

  16. Squamous Cell • Premalignant Lesions • Actinic Keratosis • Most common • Sun exposed skin • Less than 1 cm • Chance of progression – 20% • Erythematous patch with scale • Can have cutaneous horn • Pearls: Most common premalignant lesion of H & N? • AK

  17. Typical AK

  18. Cutaneous Horn

  19. Squamous Cell • Premalignant Lesions • Bowen Disease • Pearls: Squamous cell carcinoma in situ of the skin • Full thickness dysplasia of epidermis • Well circumscribed • Common with hx of arsenic exposure • Keratoacanthoma (pearls) • Benign, usually self limited • Common in older males • 2-6 mo hx of rapid growth – usually on nose • Central area of ulceration – volcano-like • Spontaneous involution

  20. Keratoacanthoma

  21. Squamous Cell • The following are features of high-risk SCC: • Size • Width greater than 2 cm • Depth greater than 4 mm • Location • Ear • Lip • Histologic features • Perineural invasion • Lymphovascular invasion • Poorly differentiated grade • Recurrence • Immunosuppression

  22. Management • Initial evaluation involves • Assessment of location • Punch or excisional biopsy • Staging

  23. AJCC Classification • TNM staging system for NMSC • Primary tumor (T) • TX - Primary tumor cannot be assessed. • T0 - No evidence of primary tumor • Tis - Carcinoma in situ • T1 - Tumor 2 cm or less • T2 - Tumor larger than 2 cm but smaller than 5 cm • T3 - Tumor larger than 5 cm • T4 - Tumor invades deep extradermal structures (bone, muscle, cartilage). • Regional lymph nodes (N) • NX - Regional lymph nodes cannot be assessed. • N0 - No regional lymph node metastasis • N1 - Regional lymph node metastases • Distant metastasis (M) • MX - Distant metastasis cannot be assessed. • M0 - No distant metastasis • M1 - Distant metastasis

  24. Management - Cryosurgery • Cryogen such as liquid Nitrogen to kill tumor cells • Typical temperature of -50°C . • Tissue-sparing, but leave open wound • Hypopigmentation and scarring may result • Limited to favorable small lesions with well-defined borders

  25. Management – Radiation Therapy • Used extensively in the past, now sparingly • High cure rate (95%) • Does not allow surgical staging • Protracted treatment course, and expensive • Radiodermatitis, delayed carcinogenesis • Currently reserved for poor operative candidates, adjuvant in high risk malignancy

  26. Photodynamic Therapy • Photosensitizing drug (porphyrin, 5-ALA) applied topically, orally or parenterally and localizes into tumor cells • Drug is activated by exposure to light (laser) • Efficacy is low (45%) • Side effects include local edema, erythema, blistering, ulceration • Used as palliation

  27. Management - Excisional Surgery • Most often used by surgeons, esp for larger lesions • Can be with cold steel or laser • Can allow reconstruction in the same sitting • Frozen sections decrease recurrence rate • Can be time consuming and inconvenient • If more than 1/3 of a cosmetic facial unit is excised, better cosmesis with removal of entire unit • Success rate 93-95%

  28. Management – Excisional Surgery

  29. Mohs Surgery - Indications • Recurrent skin cancer • Skin cancer in “high risk anatomic areas” and cosmetically important areas • Histologically aggressive skin cancer • Large skin cancers • Skin cancer with ill-defined clinical margins • Irradiated skin • Dermatofibrosarcoma Protuberans • Selected mucosal squamous cell cancers

  30. Lymphatic Dissection • No hard and fast rules governing lymphatic dissection in N0 Necks • Elective Parotidectomy for deeply invasive tumors of the periauricular region • Large SCCA (>2cm), recurrent SCCA, Marjolin’s ulcer, perineural invasion may require regional lymphadenectomy • Prophylactic neck when SCC >4 cm with deep invasion arising on cheek, neck, scalp

  31. Rare Cutaneous Malignancies • Merkel’s Cell Carcinoma • Tumor arising from pluripotential basal cells within or around hair cells (pearls) • Poorly differentiated histology • High rate of recurrence and lymph node metastasis requires excisional surgery with adjuvant radiation and treatment of lymphatic drainage in most cases • NO neck should be treated • Solitary erythematous to deep purple plaque or nodule of up to several centimeters in size

  32. Rare Cutaneous Malignancies • Dermatofibrosarcoma Protuberans • Arises in dermis, spreads deeply • Large indurated plaque with firm irregular flesh colored nodules • Mohs is treatment of choice • Pilomatrix Carcinoma • Arises from Pilomatricoma, a benign tumor of hair matrix origin • Aggressive wide local excision is treatment

  33. THE END Questions?

More Related